MEI Pharma Rebrands as Litecoin Strategy (LITS) — Shares Surge 10.61%, Market Cap Reaches $101M

MEI Pharma Rebrands as Litecoin Strategy (LITS) — Shares Surge 10.61%, Market Cap Reaches $101M
Litecoin Treasury Firm MEI Pharma Rebrands as Lite Strategy; Ticker Changes to LITS as Charlie Lee Joins Board
MEI Pharma’s $100M Move to Litecoin: Exploring Potential Impacts on Market Dynamics and Institutional Adoption
MEI Pharma Makes Litecoin Its Primary Treasury Asset
MEI Pharma’s Crypto Treasury Move: 930,000 Litecoin Tokens Acquired
Litecoin Gains Momentum Amid ETF Speculation and MEI Pharma’s Corporate Treasury Investment
458.3MUSD
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US5915202007
CUSIP
591520101
Sector
Technology
Industry
Electronic Components
Fiscal Year End
April
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
0.78
Book Value
19.11
Dividend Share
0.22
Dividend Yield
1.70%
Earnings Share
-1.07
Wall Street Target Price
19.33
EPS Estimate Current Year
-0.99
EPS Estimate Next Year
0.16
EPS Estimate Current Quarter
-0.21
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
1,019,200,000
Gross Profit TTM
203,000,000
EBITDA
74,000,000
Profit Margin
-3.50%
Return On Assets TTM
0.73%
Return On Equity TTM
-5.21%
Revenue Per Share TTM
28.692
Qtly Revenue Growth YOY
15.90%
Diluted Eps TTM
-1.07
Qtly Earnings Growth YOY
-96.60%
Trailing PE
0.00
Forward PE
10
Price Sales TTM
0.4772
Price Book MRQ
0.6765
Enterprise Value Revenue
0
Enterprise Value EBITDA
9
22.91
20.26%45.51
17.25%18.37
15.03%18.51
11.10%14.93
1.84%113.57
1.44%136.96
1.19%330.00
-6.99%159.30
-0.61%205.40
-0.57%